Literature DB >> 28031335

NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection.

Nikki B Marshall1, Allen M Vong1, Priyadharshini Devarajan1, Matthew D Brauner1, Yi Kuang1, Ribhu Nayar1, Elizabeth A Schutten1, Catherine H Castonguay1, Leslie J Berg1, Stephen L Nutt2,3, Susan L Swain4.   

Abstract

CD4 T cells can differentiate into multiple effector subsets, including ThCTL that mediate MHC class II-restricted cytotoxicity. Although CD4 T cell-mediated cytotoxicity has been reported in multiple viral infections, their characteristics and the factors regulating their generation are unclear, in part due to a lack of a signature marker. We show in this article that, in mice, NKG2C/E identifies the ThCTL that develop in the lung during influenza A virus infection. ThCTL express the NKG2X/CD94 complex, in particular the NKG2C/E isoforms. NKG2C/E+ ThCTL are part of the lung CD4 effector population, and they mediate influenza A virus-specific cytotoxic activity. The phenotype of NKG2C/E+ ThCTL indicates they are highly activated effectors expressing high levels of binding to P-selectin, T-bet, and Blimp-1, and that more of them secrete IFN-γ and readily degranulate than non-ThCTL. ThCTL also express more cytotoxicity-associated genes including perforin and granzymes, and fewer genes associated with recirculation and memory. They are found only at the site of infection and not in other peripheral sites. These data suggest ThCTL are marked by the expression of NKG2C/E and represent a unique CD4 effector population specialized for cytotoxicity.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28031335      PMCID: PMC5263106          DOI: 10.4049/jimmunol.1601297

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  77 in total

1.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Robin Kageyama; Danelle Eto; Tania C Escobar; Robert J Johnston; Laurel Monticelli; Christopher Lao; Shane Crotty
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

Review 2.  Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B.

Authors:  Inna S Afonina; Sean P Cullen; Seamus J Martin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

4.  Cutting edge: MHC class II-restricted killing in vivo during viral infection.

Authors:  Evan R Jellison; Sung-Kwon Kim; Raymond M Welsh
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

5.  CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Authors:  Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

6.  Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.

Authors:  Yu Yao; Jens Vent-Schmidt; Matthew D McGeough; May Wong; Hal M Hoffman; Theodore S Steiner; Megan K Levings
Journal:  J Immunol       Date:  2015-06-08       Impact factor: 5.422

7.  Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells.

Authors:  D J Topham; P C Doherty
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

9.  CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection.

Authors:  Jacob E Kohlmeier; Tres Cookenham; Shannon C Miller; Alan D Roberts; Jan P Christensen; Allan R Thomsen; David L Woodland
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

10.  Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes.

Authors:  Daniel Mucida; Mohammad Mushtaq Husain; Sawako Muroi; Femke van Wijk; Ryo Shinnakasu; Yoshinori Naoe; Bernardo Sgarbi Reis; Yujun Huang; Florence Lambolez; Michael Docherty; Antoine Attinger; Jr-Wen Shui; Gisen Kim; Christopher J Lena; Shinya Sakaguchi; Chizuko Miyamoto; Peng Wang; Koji Atarashi; Yunji Park; Toshinori Nakayama; Kenya Honda; Wilfried Ellmeier; Mitchell Kronenberg; Ichiro Taniuchi; Hilde Cheroutre
Journal:  Nat Immunol       Date:  2013-01-20       Impact factor: 25.606

View more
  29 in total

1.  Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.

Authors:  Il-Kyu Choi; Zhe Wang; Qiang Ke; Min Hong; Yu Qian; Xiujuan Zhao; Yuting Liu; Hye-Jung Kim; Jerome Ritz; Harvey Cantor; Klaus Rajewsky; Kai W Wucherpfennig; Baochun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

Review 2.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

Review 3.  Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.

Authors:  Andrea J Sant; Katherine A Richards; Jennifer Nayak
Journal:  Curr Opin Immunol       Date:  2018-04-02       Impact factor: 7.486

4.  Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.

Authors:  Dmitri I Kotov; Jessica A Kotov; Michael F Goldberg; Marc K Jenkins
Journal:  J Immunol       Date:  2018-02-07       Impact factor: 5.422

5.  Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4+ T Cells.

Authors:  Roberto Tinoco; Florent Carrette; Monique L Henriquez; Yu Fujita; Linda M Bradley
Journal:  J Immunol       Date:  2018-02-28       Impact factor: 5.422

6.  CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection.

Authors:  Anthony DiPiazza; Nathan Laniewski; Ajitanuj Rattan; David J Topham; Jim Miller; Andrea J Sant
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

7.  Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Authors:  Samuel J Balin; Matteo Pellegrini; Eynav Klechevsky; Sohui T Won; David I Weiss; Aaron W Choi; Joshua Hakimian; Jing Lu; Maria Teresa Ochoa; Barry R Bloom; Lewis L Lanier; Steffen Stenger; Robert L Modlin
Journal:  Sci Immunol       Date:  2018-08-31

8.  IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo.

Authors:  Vinayak Brahmakshatriya; Yi Kuang; Priyadharshini Devarajan; Jingya Xia; Wenliang Zhang; Allen Minh Vong; Susan L Swain
Journal:  J Immunol       Date:  2017-03-01       Impact factor: 5.422

9.  Virus-induced natural killer cell lysis of T cell subsets.

Authors:  Keith A Daniels; Carey L O'Donnell; Catherine Castonguay; Tara M Strutt; K Kai McKinstry; Susan L Swain; Raymond M Welsh
Journal:  Virology       Date:  2019-10-18       Impact factor: 3.616

10.  Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma.

Authors:  Xao X Tang; Hiroyuki Shimada; Naohiko Ikegaki
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.